Education
About Us
Working with TipRanks
Follow Us
Bloomios (BLMS)
OTHER OTC:BLMS
BLMS Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.02
Previous CloseN/A
Volume450.00K
Average Volume (3M)4.13M
Market Cap
$6.45K
Enterprise Value$24.78M
Total Cash (Recent Filing)$2.15K
Total Debt (Recent Filing)$24.58M
Price to Earnings (P/E)―
Beta-1.19
Next Earnings
May 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding64,473,240
10 Day Avg. Volume4,127,172
30 Day Avg. Volume4,127,172
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-9.49
Price to Sales (P/S)2.06
P/FCF Ratio-1.97
Enterprise Value/Market Cap3.84K
Enterprise Value/Revenue3.01
Enterprise Value/Gross Profit12.06
Enterprise Value/Ebitda-0.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BLMS FAQ
What was Bloomios’s price range in the past 12 months?
Bloomios lowest stock price was $0.01 and its highest was $0.02 in the past 12 months.
What is Bloomios’s market cap?
Bloomios’s market cap is $6.45K.
When is Bloomios’s upcoming earnings report date?
Bloomios’s upcoming earnings report date is May 09, 2025 which is 232 days ago.
How were Bloomios’s earnings last quarter?
Currently, no data Available
Is Bloomios overvalued?
According to Wall Street analysts Bloomios’s price is currently Overvalued.
Does Bloomios pay dividends?
Bloomios does not currently pay dividends.
What is Bloomios’s EPS estimate?
Bloomios’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bloomios have?
Bloomios has 64,473,240 shares outstanding.
What happened to Bloomios’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bloomios?
Currently, no hedge funds are holding shares in BLMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bloomios
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.